The increased risk remained significant for KIM-1, UPAR, MMP12, cathepsin L1, TNFR2, and CX3CL1 after adjustments for cardiovascular risk factors (i.e., diabetes, systolic blood pressure, blood lipids, use of blood pressure or lipid-lowering medications and waist circumference). This evidence concerns the gene HAVCR1 and diabetes mellitus.